Drug Discovery

SARS-CoV-2 virus particles
#Antibodies #Biomarkers #Clinical trials #Coronavirus #Covid-19 #Drug development #SARS-CoV-2

SARS-CoV-2 antigen levels could predict patient outcomes

The amount of SARS-CoV-2 antibodies in the blood of patients hospitalised with Covid-19 could be used to predict illness severity and other clinical outcomes.  A new study, published in the Annals of Internal Medicine, shows that higher levels of viral antigen in the blood, which… Read More

#Covid-19 #News

#Breast cancer #Drug discovery #Oncology

Nitric oxide could form treatment approach for breast cancer

A new therapeutic approach for triple negative breast cancer using nitric oxide is being explored by researchers at the medical research centre CÚRAM. Amir Abdo Alsharabasy, a CÚRAM doctoral candidate working in the laboratory of Professor Abhay Pandit, is working on the design of nitric oxide scavengers to form a… Read More

#News

#Drug discovery #Spinal cord injury #Stem cells

Latent stem cells could repair spinal cord damage

A group of latent stem cells could be the key to developing new therapeutic approaches to treat brain and spinal cord injuries, research shows. Scientists at the Francis Crick Institute identified a group of latent stem cells in mice which respond to injury in the central nervous system. If the… Read More

#News

#Antibody #Drug discovery #Monoclonal antibodies #Webinar

Webinar – applications in early monoclonal antibody discovery

In this webinar, Christina Pettus, Senior Scientist, Charles River Laboratories, provides insights into how the company incorporates Octet Bio-Layer Interferometry (BLI) into its monoclonal antibody discovery workflow for discovery campaigns, antibody optimisation, and IgG characterisation. The webinar elaborates on the use of the Octet BLI for quality control of proteins,… Read More

#News

#Drug discovery #Organoids

Latest guide: A life scientist’s how-to guide for organoids

Learn best practices to consider for organoid work, as well as how to use Corning Matrigel matrix and other products to support research. Organoids have gained popularity over the years due to their ability to self-organise into “mini-organs” capable of recapitulating their respective organ-specific functions. Read More

#News

#Drug discovery #EMA #Funding #Huntington's disease #Monkeypox #Start-ups

This week in drug discovery (21 – 25 August)

News round-up for 21-25 August by DDW Editor Reece Armstrong A treatment for Monkeypox, spider venom for drug discovery and funding for international start-ups are some of the stories in this week’s news round-up. Covid researchers launch Monkeypox study   A new study investigating a potential treatment… Read More

#News

#Drug discovery #Peptides #Pharmaceutical research #Proteins

Spider venom and heart attacks? Australian centre examines

Using deadly spider venom to treat heart attacks is one of many new discoveries currently being developed at a national research centre headquartered at The University of Queensland. The Australian Research Council (ARC) Centre of Excellence for Innovations in Peptide and Protein Science (CIPPS) was launched this week at its… Read More

#Editor's Choice #News

#Drug discovery #High Throughput #Monoclonal antibodies #Webinar

Webinar: Applications in early monoclonal antibody discovery

Charles River, Antibody Discovery group, has integrated computational immunology, antibody engineering and phage display technologies into its comprehensive antibody discovery platforms that rapidly deliver antibody hits or optimised variants with a range of affinities, cross-species coverage, and improved drug-like characteristics. Charles River uses label-free biosensors and other bioanalytical assays to… Read More

#News

#AI / data analytics / healthtech / informatics #Drug discovery #ELRIG #Lab automation

The automated lab and the human: DDW Tech Theatre at ELRIG Drug Discovery

DDW is delighted to announce that Adam Prosho, Global ILS Training Director, CBRE, will be taking part the Tech Theatre at ELRIG’s Drug Discovery 2022.   Supported by DDW, the Tech Theatre will feature a series of seminars focused on automation and technology for drug discovery. … Read More

#News

#CRISPR screening #Drug discovery #Library screening

Synthego launches cell libraries to improve CRISPR-based drug discovery  

Genome engineering company Synthego has launched a portfolio of Engineered Cell Libraries to help improve access to CRISPR-edited cells for direct use in functional screening assays.   The company’s Engineered Cell Libraries are designed to provide speed, scalability, and efficiency to accelerate the drug discovery… Read More

#News

#AI / data analytics / healthtech / informatics #Automation / robotics #Drug discovery #ELRIG

Informatics and data handling: DDW Tech Theatre at ELRIG Drug Discovery 

Samantha Kanza, Senior Enterprise Fellow, University of Southampton, will be speaking at the ELRIG Tech Theatre supported by DDW at this year’s ELRIG Drug Discovery 2022.  The Tech Theatre will feature a series of seminars focused on automation and technology for drug discovery.  The event… Read More

#News

#Drug development #Immunology / Virology & Vaccines #Lyme Disease #Pfizer

Pfizer launches Phase III trial for Lyme disease vaccine  

Pfizer has launched a Phase III clinical trial of a vaccine to protect people against Lyme disease, in collaboration with pharmaceutical company Valneva.   The Vaccine Against Lyme for Outdoor Recreationists (VALOR) trial will investigate the efficacy, safety and immunogenicity of Pfizer and Valneva’s Lyme disease vaccine… Read More

#News

Scientist looking through microscope
#Assay #Biologics / Biotechnology #Biopharma #Drug development #Ingredients / APIs / Fine chemicals

Addressing the challenge of salt forms in drug discovery

Listen to this article on the DDW Podcast: Some 5% of commercially available research compounds are sold as salt forms. These can have better properties than their parents, including preferable stability, solubility, bioavailability, and manufacturability. By selecting the correct salt form for an assay or as a… Read More

#Exclusive Content #Opinion

#Cellular imaging #Drug discovery #Medicines Discovery Catapult

MDC and ZEISS look to advance microscopy for early drug discovery  

A new partnership has been formed between Medicines Discovery Catapult (MDC) and technology group ZEISS to improve drug discovery using advanced microscopy solutions.  The partnership will combine MDC’s expertise in cell biology and drug discovery with ZEISS’ microscope instrumentation and image analysis capabilities. In particular, the organisations… Read More

#News

#Biopharma #Drug discovery #Evonetix #Organoids #Synthetic biology

Synthetic biology e-book out now  

This e-book, sponsored by Evonetix, contains exclusive insight from industry experts on how synthetic biology is innovating and advancing drug discovery.   Key topics include:   Four key approaches to synthetic biology  The global advances in synthetic biology drug discovery Why synthetic biology is the next big… Read More

#News